MedTrace Logo

Personalized Evidence-based Medicine in Patients With Atrial Fibrillation

NCT04774341 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4200

Last updated 2021-03-02

No results posted yet for this study

Summary

A retrospective analysis

Conditions

  • Adherence to Personalized EBM Anticoagulant Treatment in Patients at High Risk for Stroke

Interventions

DRUG

anticoagulation treatment

Adherence to personalized evidence-based anticoagulant treatment in patients at high risk for stroke with atrial fibrillation

Sponsors & Collaborators

  • Center for New Medical Technologies, Novosibirsk, Russia

    collaborator OTHER

  • I.M. Sechenov First Moscow State Medical University

    collaborator OTHER

  • University of Rochester

    collaborator OTHER

  • Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health

    collaborator OTHER

  • Center of Personalized Medicine, Pirogova

    lead OTHER

Principal Investigators

  • Evgeny Pokushalov, Prof. MD PhD · Center for New Medical Technologies, Novosibirsk, Russia

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-10
Primary Completion
2021-02-24
Completion
2021-02-24

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04774341 on ClinicalTrials.gov